129 related articles for article (PubMed ID: 20574056)
1. Effect of lisdexamfetamine dimesylate on sleep in children with ADHD.
Giblin JM; Strobel AL
J Atten Disord; 2011 Aug; 15(6):491-8. PubMed ID: 20574056
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
Findling RL; Childress AC; Cutler AJ; Gasior M; Hamdani M; Ferreira-Cornwell MC; Squires L
J Am Acad Child Adolesc Psychiatry; 2011 Apr; 50(4):395-405. PubMed ID: 21421179
[TBL] [Abstract][Full Text] [Related]
3. Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis.
Lopez FA; Ginsberg LD; Arnold V
Postgrad Med; 2008 Sep; 120(3):89-102. PubMed ID: 18824828
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design.
Coghill DR; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson CS; Civil R; Dauphin M; Higgins N; Lyne A; Gasior M; Squires LA
J Am Acad Child Adolesc Psychiatry; 2014 Jun; 53(6):647-657.e1. PubMed ID: 24839883
[TBL] [Abstract][Full Text] [Related]
5. Effect size of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
Wigal T; Brams M; Gasior M; Gao J; Giblin J
Postgrad Med; 2011 Mar; 123(2):169-76. PubMed ID: 21474905
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
Najib J
Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
[TBL] [Abstract][Full Text] [Related]
7. Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical trial in adults with attention-deficit/hyperactivity disorder.
Adler LA; Weisler RH; Goodman DW; Hamdani M; Niebler GE
J Clin Psychiatry; 2009 Dec; 70(12):1652-61. PubMed ID: 20141706
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover study.
Boellner SW; Stark JG; Krishnan S; Zhang Y
Clin Ther; 2010 Feb; 32(2):252-64. PubMed ID: 20206783
[TBL] [Abstract][Full Text] [Related]
9. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study.
Biederman J; Boellner SW; Childress A; Lopez FA; Krishnan S; Zhang Y
Biol Psychiatry; 2007 Nov; 62(9):970-6. PubMed ID: 17631866
[TBL] [Abstract][Full Text] [Related]
10. Understanding the effect size of lisdexamfetamine dimesylate for treating ADHD in children and adults.
Faraone SV
J Atten Disord; 2012 Feb; 16(2):128-37. PubMed ID: 20837983
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.
Brams M; Weisler R; Findling RL; Gasior M; Hamdani M; Ferreira-Cornwell MC; Squires L
J Clin Psychiatry; 2012 Jul; 73(7):977-83. PubMed ID: 22780921
[TBL] [Abstract][Full Text] [Related]
12. Prediction of placebo response in 2 clinical trials of lisdexamfetamine dimesylate for the treatment of ADHD.
Waxmonsky JG; Waschbusch DA; Glatt SJ; Faraone SV
J Clin Psychiatry; 2011 Oct; 72(10):1366-75. PubMed ID: 21367347
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with ADHD.
Dupaul GJ; Weyandt LL; Rossi JS; Vilardo BA; O'Dell SM; Carson KM; Verdi G; Swentosky A
J Atten Disord; 2012 Apr; 16(3):202-20. PubMed ID: 22166471
[TBL] [Abstract][Full Text] [Related]
14. Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study.
Adler LA; Dirks B; Deas P; Raychaudhuri A; Dauphin M; Saylor K; Weisler R
BMC Psychiatry; 2013 Oct; 13():253. PubMed ID: 24106804
[TBL] [Abstract][Full Text] [Related]
15. The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial.
Childress AC; Arnold V; Adeyi B; Dirks B; Babcock T; Scheckner B; Lasser R; Lopez FA
J Atten Disord; 2014 Feb; 18(2):123-32. PubMed ID: 22740112
[TBL] [Abstract][Full Text] [Related]
16. The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm.
Biederman J; Fried R; Hammerness P; Surman C; Mehler B; Petty CR; Faraone SV; Miller C; Bourgeois M; Meller B; Godfrey KM; Reimer B
J Psychiatr Res; 2012 Apr; 46(4):484-91. PubMed ID: 22277301
[TBL] [Abstract][Full Text] [Related]
17. Clinically relevant changes in emotional expression in children with ADHD treated with lisdexamfetamine dimesylate.
Katic A; Ginsberg L; Jain R; Adeyi B; Dirks B; Babcock T; Scheckner B; Richards C; Lasser R; Turgay A; Findling RL
J Atten Disord; 2012 Jul; 16(5):384-97. PubMed ID: 21173426
[TBL] [Abstract][Full Text] [Related]
18. Does prior exposure to stimulants in children with ADHD impact cardiovascular parameters from lisdexamfetamine dimesylate?
Wigal SB; Jun A; Wong AA; Stehli A; Steinberg-Epstein R; Lerner MA
Postgrad Med; 2010 Sep; 122(5):27-34. PubMed ID: 20861585
[TBL] [Abstract][Full Text] [Related]
19. The use of lisdexamfetamine dimesylate for the treatment of ADHD.
Childress AC; Sallee FR
Expert Rev Neurother; 2012 Jan; 12(1):13-26. PubMed ID: 22243042
[TBL] [Abstract][Full Text] [Related]
20. Impact of stimulant pharmacotherapy on sleep quality: post hoc analyses of 2 large, double-blind, randomized, placebo-controlled trials.
Surman CB; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):903-8. PubMed ID: 21824454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]